Seagen Inc.
Glycan-Interacting Compounds and Methods of Use
Last updated:
Abstract:
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include humanized antibodies, derivatives and fragments thereof as well as related compositions and kits. Methods of using glycan-interacting antibodies for treatment and diagnosis are included.
Status:
Application
Type:
Utility
Filling date:
1 Dec 2021
Issue date:
18 Aug 2022